Porcine vaccines offer a vast-array of benefits for the treatment of swine-related diseases. The rising prevalence of diseases like porcine epidemic diarrhea (PED), swine influenza, porcine reproductive & respiratory syndrome (PRRS), etc. is expected to accelerate the growth of the market in striking fashion. Additionally, the rising number of biotechnology companies, government initiatives for funding agriculture and animal husbandry sector, growing number of research organizations engaged in R&D activities, and burgeoning demand for porcine meat and gelatin are some of the other drivers of the global market. Amidst the drivers in the market, the high cost of vaccines associated with its storage is projected to be a leading constraint to the overall growth of the market during the review period.
The report released by Market Research Future (MRFR) on the porcine vaccines market provides us with an in-depth and detailed overview of the global market. The report starts that the market is expected to grow in an impressive fashion during the forecast period. The market valuation is projected to surpass well past its 2017 figure of USD 1910.7 million and is expected to grow at a CAGR of 7.1% during the forecast period (2018-2023).
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7438
Market Segmentation
The global porcine vaccines market segmentation is divided on the basis of disease indication, type, region, and end-user.
By type, the market includes Conjugate vaccines, live attenuated vaccines, inactivated vaccines, Toxoid vaccines, DNA vaccines, and Recombinant vaccines.
By disease indication, the market segments into Swine influenza, PED (Porcine Epidemic Diarrhea), Porcine Circovirus Associated Disease (PCVAD), PRRS (Porcine Reproductive & Respiratory Syndrome), Aujeszky's disease (AD), and others.
By end-user, the market divides into Hog Production Farm and Veterinary Hospitals.
By region, the porcine vaccines market covers Americas, Asia Pacific, Europe, and the Middle East and Africa. Furthermore, North America breaks into the US and Canada; Asia Pacific divides into India, China, Japan, South Korea, Australia, and Rest of Asia Pacific; Europe divides into Western and Eastern Europe.
Regional Analysis
Among the mentioned regions covered by the porcine vaccines market, the Americas hold the dominant share and stand tall with the leading position. The growth and positioning of the region can be owed to the rising number of pig farms and rising swine-based diseases like swine influenza, PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), etc. Add to this, the fast-paced increase in contract farming as well as independent farming for the cultivation of pig is also identified as a major driver of the regional market.
Europe holds the second largest position in the global porcine vaccination market and is expected to retain its positioning in the forthcoming years of the forecast period. The growth of the market is attributed to the expanding number of production units for swine and a high consumption rate of pork meat.
The Asia Pacific region is expected to hold the potential to be the fastest growing region in the porcine vaccines market. The factors contributing to the growth of the market are animal associations, initiatives undertaken by various government agencies, and high opportunities of growth for major players in the market in regard to setting up their manufacturing plants in the region.
The Middle East & Africa region boasts the least share in the global porcine vaccines market. The region is anticipated to be majorly spearheaded by the Middle East due to the increasing government initiatives for the animal care industry.
Competitive Landscape
The global porcine vaccines market includes several leading players, including names such as Sanofi S.A., Ceva Sante Animale, PBS Animal Health, Bayer AG, Bimeda, Inc., Aptimmune, Merck & Co., Inc., Eli Lilly and Company, Zoetis, Inc., Boehringer Ingelheim International GmbH, Vetoquinol S.A., and others.
April 12th, 2019, MSD Animal Health made an announced concerning the launch of its new and innovative triple action sowcare vaccine to fight against lep-tospirosis, porcine parvovirosis, and erysipelas.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/porcine-vaccines-market-7438
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
